Page 1

866 scientific 13 October 2026 September 2026 Quarterly Trading Report XRF Scientific Ltd ( " XRF " or " The Company " ) provides an update on the September 2026 quarterly financial results ( unaudited ) : Quarter results for period ended 30 September Revenue Profit Before Tax September 2026 Quarter $ 21.1m $ 4.4m September 2025 Quarter $ 15.3m $ 3.4m Change % 38 % 30 % The September 2026 quarter was a very strong period , with all divisions contributing to the result . The September quarter has historically been XRF's least profitable period each financial year , with this quarter's growth driven by strong momentum in consumable and capital equipment sales . The result includes costs related to the integration of the CGA acquisition which have not been adjusted . Our new office in India was profitable for the quarter and is continuing to grow sales in a large addressable market . Consumable sales were $ 5.6m for the quarter compared to $ 4.4m in the Previous Corresponding Period ( PCP ) . The strong level of sales activity was driven by customers both in Australia and internationally . Conditions for consumable sales have remained positive for the first part of October . Sales of capital equipment products were $ 5.9m compared to $ 5.0m in the PCP . Orbis increased revenue by 66 % to $ 2.4m , which was driven by commercial labs and the gold sector . Orbis crushers continue to be adopted in key markets due to their superior performance . Customers are also increasingly integrating Orbis crushers into robotic sample preparation cells for increased automation . During the quarter two new Orbis products were released , the OM25 crusher for smaller labs and the Standalone RSD / LSD . We expect Orbis to have a very strong December quarter , with our already large order book expected to grow significantly . Integration of the CGA product line is progressing well , with production of instruments expected to start in Perth during December Q2 . A large backlog of CGA instrument orders is building , which is expected to start converting into sales during the next quarter . Revenue for CGA spare parts and servicing is continuing as normal . Under the transition all major distributors have been retained , which has provided new channels for selling other products such as xrTGA and CS - 1232 . Precious metals product sales were $ 9.6m for the quarter compared to $ 5.9m in the PCP . With the platinum price reducing , new metal product sales have increased back to normalised levels . Recycling of platinum products are also at positive levels , which is primarily being driven by activity in the mining sector . Sales included a one - off $ 2.05m precious metals sale , with a margin of $ 0.1m , which related to the closure of a platinum inventory lease . The off - balance - sheet lease was no longer required , as the division has been building its own platinum inventory position over the last decade . Rather than returning the metal , it was sold on behalf of the Lessor at their request . XRF Scientific Ltd ( ABN 80 107 908 314 ) 86 Guthrie Street , Osborne Park , Western Australia 6017 investors@xrfscientific.com T +61 8 9244 0600